香港Mr. OS和Ms. OS队列中老年华人髋部骨折预防的骨质疏松筛查策略成本效果:决策树建模研究
该研究基于香港Mr. OS和Ms. OS队列构建决策树模型,评估不同骨质疏松筛查策略联合阿仑膦酸钠治疗5年对比不筛查的成本效果。结果显示,对65岁及以上华人,双能X线吸收法(DXA)筛查无论是否联合骨折风险评估工具(FRAX)或跟骨超声预筛,均比不筛查更具成本效果;概率敏感性分析显示70岁及以上人群中FRAX预筛后药物治疗占主导。
要点
- 对65岁及以上香港华人,DXA筛查联合或不联合FRAX或跟骨超声预筛均比不筛查更具成本效果。
- 概率敏感性分析显示70岁及以上人群中FRAX预筛后骨质疏松药物治疗占主导。
- 对治疗依从性更乐观假设或纳入其他主要骨质疏松性骨折后,结果无实质改变。
核心结论
- 基于DXA的骨质疏松筛查策略无论是否联合预筛,对65岁及以上香港华人比不筛查更具成本效果。
研究设计与样本
- 决策树模型研究,模型输入基于香港Mr. OS和Ms. OS队列,数据来自社会福利署或已发表文献。
- 评估不同骨质疏松筛查策略后序贯5年阿仑膦酸钠治疗对比不筛查(但发生髋部骨折时治疗)的成本效果。
- 筛查策略由不同检测方法和起始年龄组构成,评估时间跨度10年,若中轴DXA T值(髋部或脊柱)≤-2.5则给予治疗。
主要发现
- 所有筛查策略(包括DXA普遍筛查及DXA前FRAX或跟骨定量超声预筛)对65岁及以上人群均一致比不筛查更具成本效果。
- 对治疗依从性更乐观假设或纳入其他主要骨质疏松性骨折的单因素敏感性分析未实质改变结果。
- 概率敏感性分析显示70岁及以上香港人群中FRAX预筛后序贯骨质疏松药物治疗占主导。
关键数值与推荐
- 中轴DXA T值(髋部或脊柱)≤-2.5时给予治疗。
- 筛查策略包括DXA普遍筛查及特定阈值FRAX或跟骨定量超声预筛后行DXA检查。
- 后续治疗为阿仑膦酸钠治疗5年。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Despite the high costs of hip fracture, many governments provide limited support for osteoporosis screening. We demonstrated that osteoporosis screening by dual-energy X-ray absorptiometry (DXA) with or without pre-screening by Fracture Risk Assessment Tool (FRAX) or calcaneal ultrasound are more cost-effective than no screening in Chinese people aged 65 or over in Hong Kong. INTRODUCTION: To examine the cost-effective potential osteoporosis screening strategies for hip fracture prevention in Hong Kong. METHODS: Decision tree models were constructed to evaluate the cost per quality-adjusted life years (QALYs) of the different osteoporosis screening strategies followed by subsequent 5-year treatment with alendronate compared to no screening (but treat if a hip fracture occurs). The multiple osteoporosis screening strategies were composed of alternative tests and initiation age groups were evaluated with a 10-year horizon, and treatment were assigned if central dual-energy X-ray absorptiometry (DXA) T-score (at either the hip or spine) is - 2.5 or less. Strategies included DXA for all people and pre-screening with the Fracture Risk Assessment Tool (FRAX) at specific thresholds or by calcaneal quantitative ultrasonography (QUS) before taking DXA examination. All the model inputs were based on the Mr. OS and Ms. OS Hong Kong cohort; data are obtained from the Social Welfare Department or the published literature. RESULTS: All of the screening strategies, including the universal screening with DXA and the pre-screening with FRAX or QUS before DXA, were consistently more cost-effective than no screening for people aged 65 years old or over. One-way sensitivity analysis with a more optimistic assumption on treatment adherence or inclusion of other major osteoporotic fractures did not change the results materially. Probabilistic sensitivity analyses showed a dominant role of pre-screening with FRAX followed by subsequent osteoporosis drug treatment in people aged 70 years old or over in Hong Kong. CONCLUSIONS: Osteoporosis screening strategies based on DXA with or without pre-screening are more cost-effective compared to no screening for Chinese people aged 65 or over in Hong Kong.
引用
- Su Y, Lai FTT, Yip BHK, et al. Cost-effectiveness of osteoporosis screening strategies for hip fracture prevention in older Chinese people: a decision tree modeling study in the Mr. OS and Ms. OS cohort in Hong Kong. Osteoporos Int. 2018. PMID: 29774400. doi:10.1007/s00198-018-4543-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。